#United States #Miami #dermatology #Galderma

Galderma Establishes New U.S. Headquarters in Miami

Galderma, recognized as a leading entity in the dermatology field, has recently unveiled its new U.S. headquarters strategically located in the vibrant city of Miami, Florida. This decision is part of the company's broader strategy to enhance its operations and drive growth in what is considered its largest market, the United States.

The new office is situated in the dynamic Brickell neighborhood, known for its thriving market in dermatological skincare and its focus on injectable aesthetics. Galderma anticipates that by 2028, approximately 150 employees will be stationed in this new location, including vital leadership positions critical to the company's success in the region.

Why Miami?

Miami has increasingly positioned itself as a premier destination for consumer skincare and aesthetic treatments. The city boasts an impressive concentration of medical spas and dermatological aesthetic clinics, with aesthetic procedures expanding significantly at a rate of 30% relative to the previous year. Furthermore, Miami is home to the second-largest medical district in the nation, encompassing a robust network of hospitals and research facilities that enhances its standing as a hub for healthcare innovation.

Flemming Ørnskov, Galderma's Chief Executive Officer, expressed confidence in Miami's alignment with the company's vision. He highlighted the city's vibrant creativity and energy as reflective of Galderma's aspirations, stating, "The city's emergence as a premium destination and a trendsetter in areas closely aligned to our activities, as well as its fast-growing healthcare professional community, makes Miami a natural choice for our U.S. headquarters." He believes that being located in Miami will attract top-tier talent essential for Galderma's ambitions.

Miami-Dade County has seen an influx of companies recognizing the area's potential as an attractive investment locale. Rodrick Miller, the President and CEO of the Miami-Dade Beacon Council, underscored this trend, noting that the region is evolving as a pivotal player in the life sciences and healthcare sector.

Maintaining a Nationwide Presence

While establishing its headquarters in Miami, Galderma will continue to support several U.S. locations. The Boston office will serve as the hub for its U.S. Therapeutic Dermatology business and Research and Development efforts. Meanwhile, Carlsbad, CA, will host operations for Alastin®, the company's premium skincare brand, and the Dallas, TX office will remain one of its significant sites. Fort Worth, TX, will continue hosting the North America distribution center, ensuring that Galderma maintains a robust national footprint.

New Leadership

In tandem with this move, Galderma has appointed Heather Wallace as the President of Galderma U.S. Wallace, based in Miami, brings extensive experience in dermatology and consumer health management. Her previous roles include CEO of Curology and President of the Americas for Revlon, showcasing her significant expertise in leading high-performing teams. Her appointment reinforces Galderma's commitment to placing forward-thinking leaders in strategically significant roles.

A Comprehensive Brand Portfolio

Galderma's offerings encompass a diverse range of flagship brands that hold dominant market positions across dermatological skincare, injectable aesthetics, and therapeutic dermatology. The Cetaphil® brand, known for its dermatologist-recommended products for sensitive skin, represents one of Galderma’s most trusted names with a legacy of over 70 years in the U.S. The company also features Alastin®, recognized for its medical-grade peptide-based skincare solutions, and maintains a rich history of innovation within the injectable aesthetics space.

The launch of a groundbreaking monoclonal antibody targeting specific dermatological conditions also marks Galderma’s commitment to pioneering advancements in therapeutic dermatology.

Conclusion

Galderma's move to Miami signifies a pivotal shift in its operational strategy, aiming to harness the strengths of a vibrant local market to accelerate its growth and innovation in dermatology. With a strong new leadership team and a comprehensive brand portfolio, Galderma looks towards a future where it continues to set trends and lead in the dermatological sector, meeting the diverse needs of consumers and healthcare professionals alike. As this evolution unfolds, Miami stands as a beacon of opportunity and growth for Galderma, further embedding its influence in the U.S. dermatological landscape.